About the company
MSD is an international biopharmaceutical company engaged in scientific research and the development of medicines, vaccines and biological therapies. It is known as Merck & Co., Inc. in the United States and Canada and operates as MSD in other markets. Its history spans more than 130 years.
The company’s activities cover the journey from exploring new approaches to treatment through manufacturing and delivery to patients. Research, clinical development, production and international collaboration are central to this work.
Key areas of activity
MSD’s research priorities include oncology, vaccines, infectious diseases, cardiometabolic and respiratory diseases, immunology, neuroscience and ophthalmology. Across these fields, the company explores new opportunities to prevent disease and address unmet treatment needs.
Alongside its human medicines and vaccines portfolio, MSD also operates in animal health. Its international manufacturing network and scientific partnerships are important elements of a global business that connects research expertise with the practical requirements of healthcare delivery.
Partnership with Zeytun
MSD is among the strategic and commercial partners of Zeytun Pharmaceuticals. This cooperation forms part of our international partnership portfolio. For further information about the partnership and related products, please contact the Zeytun Pharmaceuticals team.